Over the past 12 months, 2 insiders at Ventyx Biosciences, Inc. filed 2 open-market SEC Form 4 transactions on VTYX: 0 purchases worth $0 and 2 sales worth $463K. Insiders have been net sellers over this period. The most recent filing was on Dec 18, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 18, 25 | Raju MohanCEO AND PRESIDENT | SELL | 47.3K | $7.72 | $366K |
| Dec 18, 25 | John NussCHIEF SCIENTIFIC OFFICER | SELL | 12.7K | $7.72 | $98K |
| Apr 2, 25 | John NussCHIEF SCIENTIFIC OFFICER | SELL | 1.9K | $1.07 | $2K |
| Dec 27, 24 | John NussCHIEF SCIENTIFIC OFFICER | SELL | 21.1K | $2.36 | $50K |
| Dec 23, 24 | Sheila GujrathiDirector | BUY | 130.0K | $2.31 | $300K |
| Dec 19, 24 | John NussCHIEF SCIENTIFIC OFFICER | SELL | 13.2K | $2.26 | $30K |
| Nov 25, 24 | Raju MohanCEO AND PRESIDENT | BUY | 261.8K | $2.01 | $526K |
| Nov 22, 24 | Raju MohanCEO AND PRESIDENT | BUY | 238.2K | $1.83 | $436K |
| Apr 2, 24 | Martin AusterCHIEF FINANCIAL OFFICER | SELL | 1.4K | $5.40 | $8K |
| Apr 2, 24 | Christopher W KruegerCHIEF BUSINESS OFFICER | SELL | 1.7K | $5.40 | $9K |
| Apr 2, 24 | Raju MohanCEO AND PRESIDENT | SELL | 4.3K | $5.40 | $23K |
| Apr 2, 24 | John NussCHIEF SCIENTIFIC OFFICER | SELL | 1.7K | $5.40 | $9K |
| Dec 20, 23 | Christopher W KruegerChief Business Officer | SELL | 5.3K | $2.12 | $11K |
| Dec 20, 23 | Raju MohanCEO and President | SELL | 58.9K | $2.12 | $125K |
| Dec 20, 23 | John NussChief Scientific Officer | SELL | 17.6K | $2.12 | $37K |
| Oct 9, 23 | Nsv Partners III Gp LlcTenPercentOwner | SELL | 49.2K | $30.03 | $1.5M |
| Oct 9, 23 | Somu SubramaniamDirector,TenPercentOwner | SELL | 49.2K | $30.03 | $1.5M |
| Oct 5, 23 | Raju MohanChief Executive Officer | SELL | 30.0K | $29.11 | $873K |
| Oct 3, 23 | Christopher W KruegerChief Business Officer | SELL | 14.0K | $30.70 | $419K |
| Oct 3, 23 | John NussChief Scientific Officer | SELL | 9.3K | $30.72 | $278K |
| Sep 18, 23 | Nsv Partners III LpTenPercentOwner | SELL | 56.7K | $37.81 | $2.1M |
| Sep 18, 23 | Somu SubramaniamDirector,TenPercentOwner | SELL | 56.7K | $37.81 | $2.1M |
| Sep 5, 23 | Martin AusterChief Financial Officer | SELL | 18.3K | $33.98 | $591K |
| Sep 5, 23 | Christopher W KruegerChief Business Officer | SELL | 10.4K | $33.97 | $336K |
| Sep 5, 23 | Raju MohanChief Executive Officer | SELL | 20.6K | $33.98 | $665K |
| Sep 5, 23 | John NussChief Scientific Officer | SELL | 7.0K | $33.41 | $225K |
| Aug 31, 23 | William J. SandbornSee Remarks | SELL | 11.9K | $33.64 | $400K |
| Aug 8, 23 | William J. SandbornSee Remarks | SELL | 2.1K | $33.12 | $68K |
| Aug 7, 23 | Raju MohanChief Executive Officer | SELL | 20.2K | $35.01 | $671K |
| Aug 3, 23 | Christopher W KruegerChief Business Officer | SELL | 13.3K | $35.91 | $473K |
| Aug 3, 23 | John NussChief Scientific Officer | SELL | 8.9K | $35.92 | $316K |
| Jul 31, 23 | William J. SandbornSee Remarks | SELL | 11.9K | $37.16 | $442K |
| Jul 31, 23 | Nsv Partners III LpTenPercentOwner | SELL | 10.8K | $37.59 | $406K |
| Jul 31, 23 | Somu SubramaniamDirector,TenPercentOwner | SELL | 10.8K | $37.59 | $406K |
| Jul 28, 23 | Nsv Partners III LpTenPercentOwner | SELL | 611 | $37.53 | $23K |
| Jul 28, 23 | Somu SubramaniamDirector,TenPercentOwner | SELL | 611 | $37.53 | $23K |
| Jul 25, 23 | Martin AusterChief Financial Officer | SELL | 28.0K | $35.54 | $995K |
| Jul 12, 23 | Nsv Partners III Gp LlcTenPercentOwner | SELL | 3.3K | $37.62 | $123K |
| Jul 12, 23 | Somu SubramaniamDirector,TenPercentOwner | SELL | 3.3K | $37.62 | $123K |
| Jul 11, 23 | Nsv Partners III Gp LlcTenPercentOwner | SELL | 28.6K | $37.54 | $1.1M |
| Jul 11, 23 | Somu SubramaniamDirector,TenPercentOwner | SELL | 28.6K | $37.54 | $1.1M |
| Jul 7, 23 | Nsv Partners III LpTenPercentOwner | SELL | 75.7K | $36.93 | $2.6M |
| Jul 7, 23 | Somu SubramaniamDirector,TenPercentOwner | SELL | 75.7K | $36.93 | $2.6M |
| Jul 5, 23 | Raju MohanChief Executive Officer | SELL | 17.3K | $40.32 | $653K |
| Jul 3, 23 | Christopher W KruegerChief Business Officer | SELL | 10.2K | $39.87 | $408K |
| Jul 3, 23 | Nsv Partners III LpTenPercentOwner | SELL | 80.9K | $39.76 | $3.2M |
| Jul 3, 23 | John NussChief Scientific Officer | SELL | 15.7K | $39.96 | $627K |
| Jul 3, 23 | William J. SandbornSee Remarks | SELL | 11.9K | $40.00 | $476K |
| Jul 3, 23 | Somu SubramaniamDirector,TenPercentOwner | SELL | 80.9K | $39.76 | $3.2M |
| Jun 23, 23 | William J. SandbornSee Remarks | SELL | 8.7K | $32.85 | $285K |
Over the past 12 months, insiders at Ventyx Biosciences, Inc. filed 0 open-market purchases worth $0 and 2 sales worth $463K on VTYX, which makes them net sellers over the period. The most recent Form 4 was filed on Dec 18, 25.
The largest recent open-market VTYX insider purchase in our data was $526K by Raju Mohan, CEO AND PRESIDENT, filed on Nov 25, 24.
2 different insiders at Ventyx Biosciences, Inc. filed open-market SEC Form 4 transactions on VTYX over the last 12 months.
InsiderTape plots every VTYX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Ventyx Biosciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →